BIOGEN INC.
Company Stats
- Market Cap
- $33.4B
- as of Sep 30, 2026
- Shares Outstanding
- 147.8M
- Free Float
- 99.9%
Income Statement
- Revenue
- $9.9B
- Net Income
- $1.3B
- Revenue Growth, 3Y
- -0.9%
- FCF Margin, 3Y Avg
- 20.6%
- FCF Margin, Worst Year
- 12.9%
Cash Flow
- Free Cash Flow
- $2.1B
- FCF Yield
- 6.1%
- Owner FCF Yield
- 5.3%
Balance Sheet
- Total Debt
- $6.6B
Returns & Capital
- SBC, 3Y Avg
- $282.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $9.9B | $2.1B | 20.7% |
| FY2024 | $9.7B | $2.7B | 28.1% |
| FY2023 | $9.8B | $1.3B | 12.9% |
| FY2022 | $10.2B | $1.1B | 11.2% |
| FY2021 | $11.0B | $3.4B | 30.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 23, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings Roundup for Week of Oct. 26, 2026
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back